Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

In contrast, vitamin D supplementation (β = −0.113, 95% CI −0.493 to 0.266; p = 0.56) and calcium supplementation (β = 0.101, 95% CI −0.556 to 0.758; p = 0.76) were not independently associated with BMD.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted a retrospective cross-sectional study including 1,202 hospitalized patients aged ≥70 years (mean age 85.0 ± 7.1 years) who underwent dual-energy X-ray absorptiometry at a tertiary endocrine and geriatric centre in Germany.

Source: Abstract.

We conducted a retrospective cross-sectional study including 1,202 hospitalized patients aged ≥70 years (mean age 85.0 ± 7.1 years) who underwent dual-energy X-ray absorptiometry at a tertiary endocrine and geriatric centre in Germany.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Secondary hyperparathyroidism and lower hip bone mineral density in very old hospitalized adults: a real-world endocrine bone study

Cross-sectional study · BMC Endocrine Disorders · 2026

Original publication title

Secondary hyperparathyroidism and lower hip bone mineral density in very old hospitalized adults: a real-world endocrine bone study

Stylianos Kopanos; Sandra Scheel; Bettina Eggert; Alexander Rübberdt; Christiane Muth; Ulrich Thiem; Joachim Feldkamp

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Severe vitamin D deficiency is common in very old hospitalized patients and frequently coexists with hypocalcaemia and secondary hyperparathyroidism. Elevated PTH levels are independently associated with lower hip bone mineral density, highlighting the importance of evaluating the calcium: vitamin D: PTH axis. Both suppressed and elevated TSH levels were associated with lower BMD. These findings underscore the need for comprehensive endocrine assessment of bone health in geriatric patients.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Population ageing is associated with increasing rates of osteoporosis, frailty, and functional decline. Vitamin D deficiency and disturbances in calcium: parathyroid hormone (PTH) homeostasis are common in older adults and may contribute to bone loss. However, real-world data describing the frequency and skeletal relevance of these endocrine abnormalities in very old hospitalized populations remain limited.

Source: Background

Abstract: What methods does the paper describe?

We conducted a retrospective cross-sectional study including 1,202 hospitalized patients aged ≥70 years (mean age 85.0 ± 7.1 years) who underwent dual-energy X-ray absorptiometry at a tertiary endocrine and geriatric centre in Germany. Serum 25-hydroxyvitamin D, calcium, parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), and renal function parameters were extracted from electronic medical records. Hip bone mineral density (BMD) served as the primary skeletal outcome. Multivariable linear regression models were used to assess associations between endocrine parameters and BMD after adjustment for age, sex, body mass index, and living setting.

Source: Materials and methods

Abstract: Results

Vitamin D deficiency was highly prevalent in this very old cohort. Vitamin D levels <20 ng/mL were present in 68.6% of participants with available vitamin D measurements, and levels <10 ng/mL in 45.5%. Hypocalcaemia was observed in 39.1% of participants, while elevated PTH levels occurred in 29.9%. The combination of hypocalcaemia and elevated PTH: consistent with secondary hyperparathyroidism: was identified in 13.7% of patients. Participants with elevated PTH had significantly lower hip BMD compared with those without PTH elevation (median −2.3 vs −1.9, p = 0.004).

This association remained significant after adjustment for age and sex (β −0.23, 95% CI: −0.45 to −0.01; p = 0.042). In multivariable models, increasing age (β −0.046 per year, 95% CI: −0.063 to −0.029; p < 0.001) and higher PTH levels (β −0.006 per unit, 95% CI: −0.010 to −0.002; p = 0.002) were independently associated with lower hip BMD. In contrast, vitamin D supplementation (β = −0.113, 95% CI −0.493 to 0.266; p = 0.56) and calcium supplementation (β = 0.101, 95% CI −0.556 to 0.758; p = 0.76) were not independently associated with BMD.

Living setting was also not independently associated with hip BMD after adjustment (β −0.326, 95% CI: −0.858 to 0.207; p = 0.23). Exploratory analyses suggested a U-shaped relationship between TSH and hip BMD, with both suppressed and elevated TSH levels associated with lower BMD compared with the euthyroid range.

Source: Results

Abstract: Conclusion

Severe vitamin D deficiency is common in very old hospitalized patients and frequently coexists with hypocalcaemia and secondary hyperparathyroidism. Elevated PTH levels are independently associated with lower hip bone mineral density, highlighting the importance of evaluating the calcium: vitamin D: PTH axis. Both suppressed and elevated TSH levels were associated with lower BMD. These findings underscore the need for comprehensive endocrine assessment of bone health in geriatric patients.

Source: Conclusion
Authors’ abstract

Background

Population ageing is associated with increasing rates of osteoporosis, frailty, and functional decline. Vitamin D deficiency and disturbances in calcium: parathyroid hormone (PTH) homeostasis are common in older adults and may contribute to bone loss. However, real-world data describing the frequency and skeletal relevance of these endocrine abnormalities in very old hospitalized populations remain limited.

Materials and methods

We conducted a retrospective cross-sectional study including 1,202 hospitalized patients aged ≥70 years (mean age 85.0 ± 7.1 years) who underwent dual-energy X-ray absorptiometry at a tertiary endocrine and geriatric centre in Germany. Serum 25-hydroxyvitamin D, calcium, parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), and renal function parameters were extracted from electronic medical records. Hip bone mineral density (BMD) served as the primary skeletal outcome. Multivariable linear regression models were used to assess associations between endocrine parameters and BMD after adjustment for age, sex, body mass index, and living setting.

Results

Vitamin D deficiency was highly prevalent in this very old cohort. Vitamin D levels <20 ng/mL were present in 68.6% of participants with available vitamin D measurements, and levels <10 ng/mL in 45.5%. Hypocalcaemia was observed in 39.1% of participants, while elevated PTH levels occurred in 29.9%. The combination of hypocalcaemia and elevated PTH: consistent with secondary hyperparathyroidism: was identified in 13.7% of patients. Participants with elevated PTH had significantly lower hip BMD compared with those without PTH elevation (median −2.3 vs −1.9, p = 0.004).

This association remained significant after adjustment for age and sex (β −0.23, 95% CI: −0.45 to −0.01; p = 0.042). In multivariable models, increasing age (β −0.046 per year, 95% CI: −0.063 to −0.029; p < 0.001) and higher PTH levels (β −0.006 per unit, 95% CI: −0.010 to −0.002; p = 0.002) were independently associated with lower hip BMD. In contrast, vitamin D supplementation (β = −0.113, 95% CI −0.493 to 0.266; p = 0.56) and calcium supplementation (β = 0.101, 95% CI −0.556 to 0.758; p = 0.76) were not independently associated with BMD.

Living setting was also not independently associated with hip BMD after adjustment (β −0.326, 95% CI: −0.858 to 0.207; p = 0.23). Exploratory analyses suggested a U-shaped relationship between TSH and hip BMD, with both suppressed and elevated TSH levels associated with lower BMD compared with the euthyroid range.

Conclusion

Severe vitamin D deficiency is common in very old hospitalized patients and frequently coexists with hypocalcaemia and secondary hyperparathyroidism. Elevated PTH levels are independently associated with lower hip bone mineral density, highlighting the importance of evaluating the calcium: vitamin D: PTH axis. Both suppressed and elevated TSH levels were associated with lower BMD. These findings underscore the need for comprehensive endocrine assessment of bone health in geriatric patients.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12902-026-02456-y.

Publication and source details

Original title: Secondary hyperparathyroidism and lower hip bone mineral density in very old hospitalized adults: a real-world endocrine bone study

Stylianos Kopanos; Sandra Scheel; Bettina Eggert; Alexander Rübberdt; Christiane Muth; Ulrich Thiem; Joachim Feldkamp

BMC Endocrine Disorders · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Universität Bielefeld (3146)

Open Access funding enabled and organized by Projekt DEAL.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:58:09.351704+00:00

DOI: 10.1186/s12902-026-02456-y · PMC13445846